Evidence map›Paper›PMID 28733594›Full record

ArticleScientific reports2017

CD56 Is a Pathogen Recognition Receptor on Human Natural Killer Cells.

Sabrina Ziegler, Esther Weiss, Anna-Lena Schmitt, Jan Schlegel, Anne Burgert, Ulrich Terpitz, Markus Sauer, Lorenzo Moretta, Simona Sivori, Ines Leonhardt and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 77 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Antifungal Innate Immunity.Advances in experimental medicine and biology · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Interplay of Cytokines and Chemokines in Aspergillosis.Journal of fungi (Basel, Switzerland) · 2024
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Immune Cell Degranulation in Fungal Host Defence.Journal of fungi (Basel, Switzerland) · 2021
    Review
  16. High-dimensional mass cytometry analysis of NK cell alterations in AML identifies a subgroup with adverse clinical outcome.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Sabrina ZieglerDepartment of Internal Medicine II, WÜ4i, University Hospital Wuerzburg, Wuerzburg, Germany.
Esther WeissDepartment of Internal Medicine II, WÜ4i, University Hospital Wuerzburg, Wuerzburg, Germany.
Anna-Lena SchmittDepartment of Internal Medicine II, WÜ4i, University Hospital Wuerzburg, Wuerzburg, Germany.
Jan SchlegelDepartment of Biotechnology and Biophysics, Biocenter, Julius-Maximilian-University Wuerzburg, Wuerzburg, Germany.ORCID 0000-0003-3159-8079
Anne BurgertDepartment of Biotechnology and Biophysics, Biocenter, Julius-Maximilian-University Wuerzburg, Wuerzburg, Germany.
Ulrich TerpitzDepartment of Biotechnology and Biophysics, Biocenter, Julius-Maximilian-University Wuerzburg, Wuerzburg, Germany.ORCID 0000-0003-3031-3422
Markus SauerDepartment of Biotechnology and Biophysics, Biocenter, Julius-Maximilian-University Wuerzburg, Wuerzburg, Germany.
Lorenzo MorettaImmunology Area, Pediatric Hospital Bambino Gesù, Rome, Italy.
Simona SivoriDipartimento di Medicina Sperimentale (DIMES) and Centro di Eccellenza per la Ricerca Biomedica, Universita' di Genova, Genova, Italy.ORCID 0000-0003-1279-1172
Ines LeonhardtSeptomics Research Centre, Friedrich Schiller University and Leibniz Institute for Natural Product Research and Infection Biology-Hans Knoell Institute, Jena, Germany.
Oliver KurzaiSeptomics Research Centre, Friedrich Schiller University and Leibniz Institute for Natural Product Research and Infection Biology-Hans Knoell Institute, Jena, Germany.
Hermann EinseleDepartment of Internal Medicine II, WÜ4i, University Hospital Wuerzburg, Wuerzburg, Germany.
Juergen LoefflerDepartment of Internal Medicine II, WÜ4i, University Hospital Wuerzburg, Wuerzburg, Germany. Loeffler_J@ukw.de.
Universitätsklinikum Würzburg · DEUniversity of Würzburg · DELeibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. - Hans-Knöll-Institut (HKI) · DEBambino Gesù Children's Hospital · ITUniversity of Genoa · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aspergillus (A.) fumigatus is an opportunistic fungal mold inducing invasive aspergillosis (IA) in immunocompromised patients. Although antifungal activity of human natural killer (NK) cells was shown in previous studies, the underlying cellular mechanisms and pathogen recognition receptors (PRRs) are still unknown. Using flow cytometry we were able to show that the fluorescence positivity of the surface receptor CD56 significantly decreased upon fungal contact. To visualize the interaction site of NK cells and A. fumigatus we used SEM, CLSM and dSTORM techniques, which clearly demonstrated that NK cells directly interact with A. fumigatus via CD56 and that CD56 is re-organized and accumulated at this interaction site time-dependently. The inhibition of the cytoskeleton showed that the receptor re-organization was an active process dependent on actin re-arrangements. Furthermore, we could show that CD56 plays a role in the fungus mediated NK cell activation, since blocking of CD56 surface receptor reduced fungal mediated NK cell activation and reduced cytokine secretion. These results confirmed the direct interaction of NK cells and A. fumigatus, leading to the conclusion that CD56 is a pathogen recognition receptor. These findings give new insights into the functional role of CD56 in the pathogen recognition during the innate immune response.

Indexed as

Down-RegulationActinsAspergillus fumigatusCD56 AntigenCytoskeletonFlow CytometryHumansImmunity, InnateKiller Cells, NaturalLymphocyte ActivationMicroscopy, ConfocalMicroscopy, Electron, ScanningActinsCD56 AntigenNCAM1 protein, human

Identifiers

PMID28733594
PMCPMC5522490
OpenAlexW2736217563

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.